{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:01:35Z","timestamp":1777442495810,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007417","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000}}],"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["PGSD3-487259-2016"],"award-info":[{"award-number":["PGSD3-487259-2016"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003212","name":"Sara Elizabeth O'Brien Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RO1-AI-043247"],"award-info":[{"award-number":["RO1-AI-043247"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI-106878"],"award-info":[{"award-number":["R01-AI-106878"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["CC30430"],"award-info":[{"award-number":["CC30430"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43-TW005572"],"award-info":[{"award-number":["D43-TW005572"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43-TW005572"],"award-info":[{"award-number":["D43-TW005572"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007417","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T13:31:30Z","timestamp":1559309490000},"page":"e0007417","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-3039","authenticated-orcid":true,"given":"Brandon","family":"Sit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-590X","authenticated-orcid":true,"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolutife","family":"Fakoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aklima","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajib","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1843-7000","authenticated-orcid":true,"given":"Matthew K.","family":"Waldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"M Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref2","first-page":"1","article-title":"Cholera","volume":"6736","author":"JD Clemens","year":"2017","journal-title":"Lancet (London, England)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/bbrc.1993.1046","article-title":"Occurrence of 2-O-Methyl-N-(3-Deoxy-L-glycero-tetronyl)-D-perosamine (4-amino-4,6-dideoxy-D-manno-pyranose) in Lipopolysaccharide from Ogawa but Not from Inaba O Forms of O1 Vibrio cholerae","author":"K Hisatsune","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1086\/341206","article-title":"Epidemic and Endemic Cholera Trends over a 33\u2010Year Period in Bangladesh","volume":"186","author":"IM Longini Jr.","year":"2002","journal-title":"J Infect Dis"},{"key":"ref5","first-page":"381","article-title":"Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh\u2014three years of observation","volume":"49","author":"WH Mosley","year":"1973","journal-title":"Bull World Health Organ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/00365540903289688","article-title":"Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1","volume":"42","author":"AI Khan","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/jir416","article-title":"Natural cholera infection-derived immunity in an endemic setting","volume":"204","author":"M Ali","year":"2011","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature10392","article-title":"Evidence for several waves of global transmission in the seventh cholera pandemic","volume":"477","author":"A Mutreja","year":"2011","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1128\/JCM.40.9.3296-3299.2002","article-title":"New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh","volume":"40","author":"GB Nair","year":"2002","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1012928","article-title":"The origin of the Haitian cholera outbreak strain","volume":"364","author":"C-S Chin","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/JCM.01304-06","article-title":"Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh","volume":"44","author":"GB Nair","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3201\/eid1406.080129","article-title":"Vibrio cholerae O1 hybrid El Tor Strains, Asia and Africa","volume":"14","author":"A Safa","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004183","article-title":"Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014","volume":"9","author":"F Chowdhury","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/infdis\/169.1.230","article-title":"Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR","volume":"169","author":"MJ Albert","year":"1994","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/169.3.709","article-title":"Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal","volume":"169","author":"MJ Albert","year":"1994","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.65.9.3571-3576.1997","article-title":"Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1","volume":"65","author":"F Qadri","year":"1997","journal-title":"Infect Immun"},{"key":"ref17","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017","volume":"34","journal-title":"Wkly Epidemiol Rec. 2017"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: A reanalysis","volume":"366","author":"M Ali","year":"2005","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Q Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"F Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CVI.05615-11","article-title":"Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh","volume":"19","author":"DT Leung","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study","volume":"4","author":"AS Azman","year":"2016","journal-title":"Lancet Glob Heal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh","volume":"374","author":"F Qadri","year":"2016","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"MM Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00006454-199907000-00011","article-title":"Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers","volume":"18","author":"R Lagos","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"F Qadri","year":"2007","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1073\/pnas.1431769100","article-title":"Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae.","volume":"100","author":"L Hang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"CO Tacket","year":"1992","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8423","article-title":"A live vaccine rapidly protects against cholera in an infant rabbit model","volume":"10","author":"TP Hubbard","year":"2018","journal-title":"Sci Transl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00047-10","article-title":"Back to the future: studying cholera pathogenesis using infant rabbits","volume":"1","author":"JM Ritchie","year":"2010","journal-title":"MBio"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1128\/IAI.00438-06","article-title":"Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice","volume":"74","author":"JE Rollenhagen","year":"2006","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e2683","DOI":"10.1371\/journal.pntd.0002683","article-title":"Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide","volume":"8","author":"MM Alam","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/CVI.05689-11","article-title":"Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice","volume":"19","author":"AA Tarique","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e0003881","DOI":"10.1371\/journal.pntd.0003881","article-title":"A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice","volume":"9","author":"MA Sayeed","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 121","key":"ref35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/infdis\/121.Supplement.S124","article-title":"The relation between the persistence of El Tor vibrio in the intestines of germfree mice and so-called coproantibody","volume":"121","author":"S Sasaki","year":"1970","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1128\/IAI.64.10.4373-4377.1996","article-title":"Development of a germfree mouse model of Vibrio cholerae infection","volume":"64","author":"JR Butterton","year":"1996","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.68.2.977-981.2000","article-title":"Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains","volume":"68","author":"TI Crean","year":"2000","journal-title":"Infect Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/IAI.34.1.296-298.1981","article-title":"Experimental cholera in germfree suckling mice","volume":"34","author":"T Shimamura","year":"1981","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/infdis\/jiy414","article-title":"Cholera: Immunity and Prospects in Vaccine Development","volume":"218","author":"JB Harris","year":"2018","journal-title":"J Infect Dis"},{"key":"ref40","first-page":"e00265","article-title":"A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single \u22652x108 colony forming units [cfu] standard-dose versus a \u22652x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccine, with Shanchol as an open-label immunologic comparator","volume":"24","author":"SO Sow","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/432074","article-title":"Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh","volume":"192","author":"F Qadri","year":"2005","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e00098","DOI":"10.1128\/CVI.00098-17","article-title":"Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Na\u00efve Population","volume":"24","author":"DJ Haney","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor","volume":"62","author":"WH Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/125.5.480","article-title":"Experimental cholera in infant mice: protective effects of antibody","volume":"125","author":"W Chaicumpa","year":"1972","journal-title":"J Infect Dis"},{"key":"ref45","first-page":"65","article-title":"Experimental Cholera in Mice. I. First Report on the Oral Infection","volume":"10","author":"A Ujiye","year":"1968","journal-title":"Trop Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","article-title":"Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine","volume":"70","author":"MB Cohen","year":"2002","journal-title":"Infect Immun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e0006376","DOI":"10.1371\/journal.pntd.0006376","article-title":"Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers","volume":"12","author":"K Islam","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"ref48","first-page":"1","article-title":"Major Shift of Toxigenic V. cholerae O1 from Ogawa to Inaba Serotype Isolated from Clinical and Environmental Samples in Haiti","volume":"10","author":"MT Alam","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JB.99.3.688-695.1969","article-title":"Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae","volume":"99","author":"RB Sack","year":"1969","journal-title":"J Bacteriol"},{"key":"ref50","first-page":"37","article-title":"The plasma and mucosal IgM, IgA, and IgG responses to the Vibrio cholerae O1 protein immunome in adults with cholera in Bangladesh","author":"RC Charles","year":"2017","journal-title":"J Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"CO Tacket","year":"1992","journal-title":"J Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jir756","article-title":"Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission","volume":"205","author":"AL Bishop","year":"2012","journal-title":"J Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.00626-16","article-title":"Immunity provided by an outer membrane vesicle cholera vaccine is due to O-antigenspecific antibodies inhibiting bacterial motility","volume":"85","author":"Z Wang","year":"2017","journal-title":"Infect Immun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/IAI.01197-08","article-title":"Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae","volume":"77","author":"E Nygren","year":"2009","journal-title":"Infect Immun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41385-018-0006-7","article-title":"Oral cholera vaccination promotes homing of IgA+ memory B cells to the large intestine and the respiratory tract","volume":"11","author":"M van Splunter","year":"2018","journal-title":"Mucosal Immunol"},{"key":"ref56","article-title":"Maternal Immunization Confers Protection to the Offspring against an Attaching and Effacing Pathogen through Delivery of IgG in Breast Milk","author":"G Caballero-Flores","year":"2019","journal-title":"Cell Host Microbe"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007417","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T11:38:46Z","timestamp":1608118726000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007417"}},"subtitle":[],"editor":[{"given":"Mellisa","family":"Roskosky","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007417","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/554303","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]}}}